Guangzhou Pharmaceutical Group and Wisdom Pharmaceuticals conduct industry exchanges to jointly explore new paths for innovative drug development economics.

According to the wise pharmaceutical news, on January 20th, Chen Jiehui, Deputy Secretary of the Party Committee, Deputy Chairman, and General Manager of Guangzhou Pharmaceutical Group, led the core team to conduct in-depth research and exchange with the wise pharmaceuticals. During the discussion, both sides had in-depth exchanges on topics such as cutting-edge pharmaceutical research and development technology, AI intelligent manufacturing, innovative drug development, and market collaboration. They reached consensus on promoting strategic cooperation, establishing a regular docking mechanism, etc. In the future, both sides will continue to maintain close communication, jointly build a new model of collaborative development in the innovative drug industry, and create a bio-pharmaceutical innovation platform with international competitiveness.